Development of Radiolabeled Probes Directed against Sigma-1 Receptors

作者：Ogawa Kazuma^*; Masuda Ryohei; Shiba Kazuhiro

来源：Bunseki Kagaku, 2017, 66(6): 403-411.

DOI：10.2116/bunsekikagaku.66.403

• sigma receptor
• imaging
• radionuclide therapy
• probe

It has been reported that sigma-1 receptors regulate the release of signaling substances in the central nervous systems and are related to various diseases, such as schizophrenia, stress disorders, dementia, amyotrophic lateral sclerosis (ALS), and cancer. If the quantification of the sigma-1 receptors is possible, the pathophysiology, the stage, and the early detection of the diseases could be understandable. Molecular imaging using Positron Emission Tomography (PET) or Single Photon Emission Computed Tomography (SPECT) and radioactive probes makes noninvasive quantification of the in vivo metabolism and function possible. Currently, only nuclear medicine diagnosis using PET or SPECT can quantify the sigma-1 receptors. Therefore, there is great expectation for the development of molecular probes to image the sigma-1 receptors specifically. In this paper, we introduce our research on the development of radiohalogen-labeled molecular probes directed against the sigma-1 receptors.

• 出版日期2017-6